ArticleFrontiers in pharmacology2026

Oral losartan yields subtherapeutic airway exposure compared to nebulized delivery and fails to improve mucociliary clearance in cystic fibrosis.

Charles D Bengtson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.